Prospective, Randomized, Double-blind Study, Parallel-group, Multi-center Trial Assessing the Effects of Escalating Doses of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolepsy.

Trial Profile

Prospective, Randomized, Double-blind Study, Parallel-group, Multi-center Trial Assessing the Effects of Escalating Doses of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolepsy.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Mar 2013

At a glance

  • Drugs Pitolisant (Primary) ; Modafinil
  • Indications Narcolepsy
  • Focus Therapeutic Use
  • Acronyms Harmony II; Harmony2
  • Most Recent Events

    • 08 Feb 2013 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
    • 08 Jun 2012 Actual patient number is 14 according to ClinicalTrials.gov.
    • 20 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top